Skip to main content

Table 1 The demographic details of the patients

From: Properties of oscillatory neuronal activity in the basal ganglia and thalamus in patients with Parkinson’s disease

Patient Age/
gender
Disease duration
(years)
Motor
UPDRS
OFF/ON
Hoehn
Yahr Score
L-dopa equivalent
doses (mg/day)
Side of micro- electrode tract of nuclei No. of neuron analyzed
4–5 Hz band oscillatory neuron(%) βFB oscillatory neuron (%) non-oscillatory neuron (%)
1 46/M 2 63.5/35.5 2.5 600 B-STN 2(28.6) 2(28.6) 3(42.9)
2 57/F 4 40/16.5 2.5 600 B-STN 6(85.7) 1(14.3) 0(0)
3 67/M 7 62.5/43 4 775 B-STN 6(54.5) 3(27.3) 2(18.2)
4 56/M 8 20/12 1.5 750 L-STN 3(42.9) 2(28.6) 2(28.6)
5 62/F 10 41.5/21 3 150 R-STN 4(80) 0(0) 1(20)
6 71/F 10 40/19 3 675 L-STN 2(33.3) 2(33.3) 2(33.3)
7 56/M 5 45/25.5 2.5 250 L-STN 3(37.5) 1(12.5) 4(50)
8 64/F 12 57.5/40 3 375 R-STN 4(50) 0(0) 4(50)
9 67/M 4 30/18.5 2.5 400 L(STN) 0(0) 2(50) 2(50)
10 66/F 7 61.5/31 3 600 B-STN 0(0) 9(90) 1(10)
11 68/M 4 52/26.5 2.5 675 B-STN 0(0) 0(0) 3(100)
12 61/F 5 44.5/24.5 2 300 L-GPi 1(14.3) 2(28.6) 4(57.1)
13 59/F 6 42.5/25.5 2.5 600 L-GPi 4(44.4) 2(22.2) 3(33.3)
14 57/M 6 56.5/32 3 600 R-GPi 8(66.7) 2(16.7) 2(16.7)
15 62/F 5 60/37.5 2.5 150 R-GPi 2(33.3) 2(33.3) 2(33.3)
16 51/F 7 52.5/26.5 2.5 400 L-GPi 3(30) 2(20) 5(50)
17 48/M 5 32.5/18 2.5 300 R-GPi 4(66.7) 1(16.7) 1(16.7)
18 58/M 10 59.5/33.5 4 600 L-GPi 1(20) 2(40) 2(40)
19 61/M 8 42/23.5 2.5 1200 L-GPi 0(0) 1(50) 1(50)
20 56/F 6 49/28 3 1800 R-GPi 0(0) 3(60) 2(40)
21 61/M 1 35/17.5 1.5 300 L-Vop/Vim 4(40)/3(30) 1(10)/1(10) 1(10)/0(0)
22 68/M 5 30/15.5 1.5 200 L-Vop/Vim 5(50)/0(0) 0(0)/0(0) 3(30)/2(20)
23 67/F 15 53/33 3 800 L-Vop/Vim 3(50)/3(50) 0(0)/0(0) 0(0)/0(0)
24 49/M 6 55/32 2.5 600 R-Vop/Vim 4(44.4)/4(44.4) 0(0)/0(0) 1(11.1)/0(0)
25 70/M 3 33/20 1.5 400 R-Vop/Vim 6(54.5)/1(9.1) 1(9.1)/1(9.1) 1(9.1)/1(9.1)
26 64/F 2 39.5/27.5 2.5 600 R-Vop/Vim 0(0)/2(100) 0(0)/0(0) 0(0)/0(0)
27 56/F 9 46.5/28.5 4 400 L-Vop/Vim 5(50)/3(30) 0(0)/1(10) 0(0)/1(10)
28 49/F 2 37.5/20.5 1.5 600 L-Vop/Vim 2(18.2)/5(45.5) 2(18.2)/1(9.1) 1(9.1)/0(0)
29 61/M 3 36.5/24 2.5 600 R-Vop/Vim 0(0)/0(0) 0(0)/0(0) 4(80)/1(20)
  1. Patients 1–11 belong to STN group, patients 12–20 belong to GPi group, patients 21–29 belong to Vop/Vim group; M, male; F, female; UPDRS, United Parkinson’s Disease Rating Scale; L-dopa equivalent daily doses (mg), calculated as sum of the dose of regular levodopa-benserazide or levodopa-carbidopa; B, Bilateral; L, Left; R, Right; No: number; βFB: β frequency band oscillatory neurons; STN: the subthalamic nucleus; GPi: the globus pallidus internus; Vop: the ventral oral posterior nucleus of thalamus; Vim: the ventral intermediate of thalamus